Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications
Conditions
Interventions
Intervention1: DEXAMETHASONE INJECTION: TAKING ASEPTIC PRECAUTIONS UNDER TOPICAL ANESTHESIA SUPRACHOROIDAL INJECTION OF 0.1ML DEXAMETHASONE BY INDIGENOUSLY DESGINED 20G STEEL SLEEVE AND INJECTED BY 26
Sponsors
GSVM MEDICAL COLLEGE
Eligibility
Inclusion criteria
Inclusion criteria: PATIENTS DIAGNOSED WITH TYPE 2 DIABETES MELLITUS WITH MILD AND MODERATE DIABETIC RETINOPATHY
Exclusion criteria
Exclusion criteria: PATIENTS NOT WILLING TO PARTICIPATE OR READY FOR FOLLOW UP. PATIENTS HAVING SEVERE DIABETIC RETINOPATHY,PROLIFERATIVE DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA. PATIENTS WITH UNCONTROLLED DIABETES. PATIENTS WITH ANY OCULAR INFECTION,RAISED INTRAOCULAR PRESSURE,ANY CORNEAL PATHOLOGY,THINNED SCLERA,SCLERITIS,STAPHYLOMA OR ANY OTHER ANTERIOR SEGMENT PATHOLOGY EXCEPT PSEUDOPHAKIC PATIENTS. PATIENTS DIAGNOSED OF ANY OTHER RETINAL OR VITREOUS PATHOLOGIES EXCEPT DIABETIC RETINOPATHY.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IMPROVEMENT IN VISUAL ACUITYTimepoint: 3-6 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| CATARCTTimepoint: 6 MONTHS- 1 YEAR;CHOROIDAL/RETINAL DETACHMENTTimepoint: 1 DAY;DECREASE IN VISUAL ACUITYTimepoint: 1 DAY- 1YEAR;RAISED INTRAOCULAR PRESSURETimepoint: 1-5 DAYS;VITRITIS/ ENDOPHTHALMITISTimepoint: 15 DAYS | — |
Countries
India
Contacts
Public ContactSHIVANG CHAURASIA
GANESH SHANKAR VIDYARTHI MEDICAL COLLEGE
Outcome results
None listed